The overall inflated cost adds to limitation of access to these drugs in resource poor nations (124)
for example, highest-risk members in tier 1 could be covered with a $0 copay, while slightly lower-risk members in tier 3 could have some coverage but a greater copay
"As long as a compounding pharmacy is licensed in the state of which they're practicing or the state that they're shipping into and that compounding pharmacy is acting under the professional obligations that they are required to do so according to FDA and USP, I have no concerns with the drugs that are being compounded," said Al Carter, the executive director of the National Association of Boards of Pharmacy
(The third, Foundayo, just got FDA approval in April, so its too new for spending data.) In 2024, Medicare spent over $19.3 billion on Ozempic and Mounjaro, according to gross spending data from CMS
Rights and permissions Open Access This article is distributed under the terms of the Creative Commons Attribution 2.0 International License ( which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
Its not just a supplement, but a lifestyle boost for those dedicated to living vigorously